Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
284 studies found for:    Open Studies | "Carcinoma, Renal Cell"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Personalized Targeted Inhibitors Treatment in Renal Cell Cancer
Condition: Carcinoma, Renal Cell
Interventions: Drug: Sunitinib;   Drug: Temsirolimus;   Drug: Sorafenib;   Drug: Pazopanib;   Drug: Everolimus;   Drug: Axitinib
2 Recruiting Safety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC; KEYNOTE-018)
Condition: Carcinoma, Renal Cell
Interventions: Drug: Pazopanib;   Drug: MK-3475
3 Recruiting Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell
Interventions: Drug: Pazopanib;   Other: Low Fat Diet
4 Recruiting PII SBRT + Microwave Ablation in Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell
Interventions: Radiation: Stereotactic Body Radiation Therapy (SBRT);   Procedure: Microwave Ablation (MWA)
5 Recruiting Intraoperative Dual-modality Imaging in Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell
Interventions: Drug: Indium-111-DOTA-Girentuximab-IRDye800CW;   Radiation: SPECT/CT;   Procedure: Intraoperative dual-modality imaging
6 Recruiting Glycosaminoglycan Scores as Predictive Biomarkers in Confined Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell
Intervention:
7 Recruiting Glycosaminoglycan Scores as Predictive Biomarkers in Advanced Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell
Intervention:
8 Recruiting Phase I/II Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: Dose Limiting Toxicity and Abscopal Effect.
Condition: Carcinoma, Renal Cell
Intervention: Radiation: Stereotactic body radiotherapy
9 Not yet recruiting Pazopanib Vs. Local Therapy for Renal Cancer With Metastases
Condition: Carcinoma, Renal Cell
Interventions: Radiation: Radiation;   Drug: Pazopanib
10 Recruiting A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100)
Condition: Renal Cell Cancer
Interventions: Drug: Avelumab (MSB0010718C);   Drug: Axitinib (AG-013736)
11 Recruiting Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors
Conditions: Carcinoma, Renal Cell;   Clear Cell Renal Cell Carcinoma
Intervention: Drug: axitinib
12 Recruiting Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma
Conditions: Carcinoma, Renal Cell;   Clear-cell Metastatic Renal Cell Carcinoma
Intervention: Biological: Nivolumab/Ipilimumab
13 Recruiting Stereotactic Ablative Body Radiation Therapy for Patients With Primary Renal Cancer
Condition: Renal Cancers
Intervention: Radiation: Stereotactic Ablative Radiation Therapy
14 Recruiting Stereotactic Radiotherapy for Renal Cancers
Condition: Renal Cancer
Interventions: Radiation: Stereotactic radiotherapy 4 x 8 Gy;   Radiation: Stereotactic radiotherapy 5 x 8 Gy;   Radiation: Stereotactic radiotherapy 4 x 10 Gy;   Radiation: Stereotactic radiotherapy 4 x 12 Gy
15 Not yet recruiting A Study Combining NeoVax, a Personalized NeoAntigen Cancer Vaccine, With Ipilimumab to Treat High-risk Renal Cell Carcinoma
Condition: Kidney Cancer
Interventions: Drug: NeoVax;   Drug: Ipilimumab
16 Recruiting Kidney Cancer DNA Registry
Condition: Renal Cancer
Interventions: Other: salvia for germline DNA;   Behavioral: the Kidney Cancer Questionnaire;   Behavioral: Family History Questionnaire (when applicable)
17 Recruiting High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer
Condition: Metastatic Clear Cell Renal Cell Carcinoma
Interventions: Drug: IL-2;   Radiation: Stereotactic Ablative Body Radiation Therapy
18 Recruiting A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Intervention: Device: CyberKnife
19 Recruiting A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)
Condition: Renal Cell Cancer
Interventions: Drug: Avelumab (MSB0010718C);   Drug: Axitinib (AG-013736);   Drug: Sunitinib
20 Recruiting Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer
Condition: Metastatic Renal Cell Cancer
Interventions: Drug: RX-0201;   Drug: Everolimus

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.